PPA
ONC

Parametric Portfolio Associates’s BeOne Medicines Ltd ONC Stock Holding History

Parametric Portfolio Associates’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$9.92M Sell
52,607
-3,246
-6% -$690K 0.01% 1360
2021
Q4 		$15.1M Sell
55,853
-8,509
-13% -$2.87M 0.01% 1120
2021
Q3 		$23.4M Sell
64,362
-1,768
-3% -$578K 0.01% 850
2021
Q2 		$22.7M Sell
66,130
-4,446
-6% -$1.47M 0.01% 895
2021
Q1 		$24.6M Sell
70,576
-9,098
-11% -$3.01M 0.01% 1008
2020
Q4 		$20.6M Sell
79,674
-5,858
-7% -$1.61M 0.01% 1031
2020
Q3 		$24.5M Buy
85,532
+6,164
+8% +$1.45M 0.02% 787
2020
Q2 		$15M Buy
79,368
+10,746
+16% +$1.75M 0.01% 1065
2020
Q1 		$8.45M Buy
68,622
+4,458
+7% +$697K 0.01% 1378
2019
Q4 		$10.6M Sell
64,164
-10,714
-14% -$1.78M 0.01% 1472
2019
Q3 		$9.17M Buy
74,878
+8,916
+14% +$1.18M 0.01% 1516
2019
Q2 		$8.18M Buy
65,962
+10,778
+20% +$1.37M 0.01% 1619
2019
Q1 		$7.28M Buy
55,184
+4,305
+8% +$581K 0.01% 1673
2018
Q4 		$7.14M Buy
50,879
+15,201
+43% +$2.02M 0.01% 1602
2018
Q3 		$6.14M Buy
35,678
+30,944
+654% +$5.2M 0.01% 1849
2018
Q2 		$728K Sell
4,734
-7,774
-62% -$1.39M ﹤0.01% 3198
2018
Q1 		$2.1M Buy
12,508
+420
+3% +$56.9K ﹤0.01% 2587
2017
Q4 		$1.18M Buy
12,088
+9,339
+340% +$855K ﹤0.01% 2928
2017
Q3 		$284K Buy
+2,749
New +$205K ﹤0.01% 3700
2017
Q2 		– Sell
-10,796
Closed -$395K – 4041
2017
Q1 		$395K Buy
10,796
+4,010
+59% +$146K ﹤0.01% 3318
2016
Q4 		$206K Buy
+6,786
New +$213K ﹤0.01% 3582

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Parametric Portfolio Associates's ONC Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its BeOne Medicines Ltd (ONC) stake by 5.8% in Q1 2022, selling an estimated $690K and leaving 52,607 shares worth $9.92M. The position accounts for 0.01% of the portfolio, ranked #1360.

Parametric Portfolio Associates first reported a position in ONC in Q4 2016 and has held it in 21 quarters since. The position peaked at $24.6M in Q1 2021. 239 funds tracked by Wall St. Rank hold ONC as of Q1 2022.

  • Parametric Portfolio Associates held 52,607 shares of BeOne Medicines Ltd worth $9.92M as of Q1 2022.
  • Parametric Portfolio Associates sold 3,246 BeOne Medicines Ltd shares in Q1 2022, an estimated $690K.
  • BeOne Medicines Ltd made up 0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #1360 holding.
  • Parametric Portfolio Associates first reported a position in BeOne Medicines Ltd in Q4 2016 and has held it in 21 quarters since.
  • Parametric Portfolio Associates's BeOne Medicines Ltd position peaked at $24.6M in Q1 2021.
  • 239 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.